financetom
Forex World Market Business Cryptocurrency Commodities MAP
financetom
Business
financetom
/
Business
/
Google Introduces 'AI Co-Scientist' to Enhance Research
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Google Introduces 'AI Co-Scientist' to Enhance Research
Feb 19, 2025 6:43 AM

09:24 AM EST, 02/19/2025 (MT Newswires) -- Alphabet's (GOOG) Google ( GOOG ) said Wednesday it is introducing "AI co-scientist," a multi-agent AI system built with Gemini 2.0 to help researchers speed up scientific and biomedical discoveries.

AI co-scientist "is intended to function as a collaborative tool for scientists," Google ( GOOG ) said, adding that it is "designed to mirror the reasoning process underpinning the scientific method."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Next Technology to Implement 200-for-1 Reverse Stock Split
Next Technology to Implement 200-for-1 Reverse Stock Split
Sep 11, 2025
04:43 PM EDT, 09/11/2025 (MT Newswires) -- Next Technology ( NXTT ) said late Thursday it will implement a 200-for-one reverse stock split before the market opens on Tuesday. No fractional shares will be issued, and any resulting fractional shares will be rounded up, the company said. Shares of the company were down 45% in recent after-hours activity. ...
 Actuate Therapeutics Announces Closing of $17.25 Million Public Offering of Common Stock, Including Full Exercise of Over-Allotment Option
Actuate Therapeutics Announces Closing of $17.25 Million Public Offering of Common Stock, Including Full Exercise of Over-Allotment Option
Sep 11, 2025
CHICAGO and FORT WORTH, Texas, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. ( ACTU ) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers through the inhibition of glycogen synthase kinase-3 beta (GSK-3β), today announced the closing of its $17.25 million underwritten public offering of 2,464,286 shares of...
 Sitime Insider Sold Shares Worth $1,586,009, According to a Recent SEC Filing
Sitime Insider Sold Shares Worth $1,586,009, According to a Recent SEC Filing
Sep 11, 2025
04:44 PM EDT, 09/11/2025 (MT Newswires) -- Vincent P Pangrazio, Executive Vice President, Chief Legal Officer & Corporate Secretary, on September 09, 2025, sold 6,443 shares in Sitime ( SITM ) for $1,586,009. Following the Form 4 filing with the SEC, Pangrazio has control over a total of 52,612 common shares of the company, with 52,612 shares held directly. SEC...
 Trailblazer Acquisition Corp. Completes Upsized $275,000,000 Initial Public Offering
Trailblazer Acquisition Corp. Completes Upsized $275,000,000 Initial Public Offering
Sep 11, 2025
New York, NY, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Trailblazer Acquisition Corp. (the “Company”) announced today the closing of its upsized initial public offering of 27,500,000 units, which includes 3,500,000 units issued pursuant to the partial exercise by the underwriters of their over-allotment option. The offering was priced at $10.00 per unit, resulting in gross proceeds of $275,000,000. The Company’s...
About
Terms and Conditions Privacy policy Cookie Settings Contact Us
Services
Login register
financetom Market Personal Finance Business Economy Cryptocurrency MAP
Links
zpostcode Recruit weather mreligion Yellowpages sport constellation shopping name game directory literature Word tour furnish Lottery tftnews lyrics News digital car dir Edu Finance
Copyright 2023-2026 - www.financetom.com All Rights Reserved